3 results
We aim to provide a neurocognitive account of communicative disabilities in patients with autism spectrum disorder (ASD), focussing on shared representations of a communicative context. We expect that ASD patients show impaired shared…
1. To identify biomarkers and methodologies (neuroimaging, eye tracking, cognition, biochemistry, proteomics, genomics, etc.) that can be used to stratify patient groups into more homogeneous subgroups and/or that predict clinical outcome of…
Objectives: 1) Assess neural and cognitive biomarkers (through eye-tracking, EEG/ERP and cognitive measures) in a community sample of infants at heightened non-familial risk for ASD and in age and gender matched low-risk controls. The HR group is…